Showing results (2451-2460 of 10,003) with videos related to

Sort By:
Pageof 1,001
Leukemia & Lymphoma|December 12, 2022
Time to second treatment can be used to predict overall survival in chronic lymphocytic leukemia: identifying risk factors to help guide treatment selectionKurt S Bantilan, Neil E Kay, Sameer A Parikh, et al.
Leukemia & Lymphoma|October 16, 2020
Patterns, risk factors and outcome predictors of posterior reversible encephalopathy syndrome in pediatric cancer patientsHanafy A Hafez, Iman Ragab, Mohamed Sedky, et al.
Leukemia & Lymphoma|January 24, 2020
Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FLPaolo Strati, Mohamed Amin Ahmed, Loretta J Nastoupil, et al.
Leukemia & Lymphoma|September 14, 2020
Glucocorticoid receptor expression in multiple myeloma patients is a predictor of survivalAlexander Pozhitkov, Michael Rosenzweig, Flavia Pichiorri, et al.
Leukemia & Lymphoma|September 14, 2020
Clinicopathological and prognostic significance of BCL2, BCL6, MYC, and IRF4 copy number gains and translocations in follicular lymphoma: a study by FISH analysisMeejeong Kim, Hee Sang Hwang, Eun Mi Son, et al.
Leukemia & Lymphoma|August 28, 2020
Prognostic value of MRD monitoring based on BCR-ABL1 copy numbers in Philadelphia chromosome positive acute lymphoblastic leukemiaArun Kumar Arunachalam, Nancy Beryl Janet, Anu Korula, et al.
Leukemia & Lymphoma|August 29, 2020
Let-7b regulates the adriamycin resistance of chronic myelogenous leukemia by targeting AURKB in K562/ADM cellsXue Zhou, Xiancheng Ma, Hang Sun, et al.
Leukemia & Lymphoma|September 16, 2020
Consolidative or palliative whole brain radiation for secondary CNS diffuse large B-Cell lymphomaTyler Walburn, Natalie S Grover, Colette J Shen, et al.
Leukemia & Lymphoma|July 16, 2021
A phase 1/2 study of the combination of acalabrutinib and vistusertib in patients with relapsed/refractory B-cell malignanciesGraham P Collins, Tracy N Clevenger, Kathleen A Burke, et al.
Leukemia & Lymphoma|July 15, 2021
Graft failure after "ex-vivo" T-cell depleted haploidentical transplantation in pediatric patients with high-risk hematological malignancies. A risk factors and outcomes analysisMiguel A Diaz, Ivan Lopez, Blanca Molina, et al.
Pageof 1,001